Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 17 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 17, Issue 4 (December 2014) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Original Articles Top SOX2 expression in the developing, adult, as well as, diseased prostate X Yu, J M Cates, C Morrissey, C You, M M Grabowska, J Zhang, D J DeGraff, D W Strand, O E Franco, O Lin-Tsai, S W Hayward and R J Matusik Prostate Cancer Prostatic Dis 2014 17: 301-309; advance online publication, August 5, 2014; 10.1038/pcan.2014.29 Abstract | Full Text Prognostic significance of YWHAZ expression in localized prostate cancer K Rüenauver, R Menon, M A Svensson, J Carlsson, W Vogel, O Andrén, M Nowak and S Perner Prostate Cancer Prostatic Dis 2014 17: 310-314; advance online publication, August 26, 2014; 10.1038/pcan.2014.32 Abstract | Full Text Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population D-L Cao, C-Y Gu, Y Zhu, B Dai, H-L Zhang, G-H Shi, Y-J Shen, Y-P Zhu, C-G Ma, W-J Xiao, X-J Qin, G-W Lin and D-W Ye Prostate Cancer Prostatic Dis 2014 17: 315-319; advance online publication, September 16, 2014; 10.1038/pcan.2014.34 Abstract | Full Text An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study L Klotz, D Drachenberg, R Singal, A Aprikian, Y Fradet, M Kebabdjian, M Zarenda and J Chin Prostate Cancer Prostatic Dis 2014 17: 320-324; advance online publication, September 2, 2014; 10.1038/pcan.2014.24 Abstract | Full Text Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer R R McKay, K A Zukotynski, L Werner, O Voznesensky, J S Wu, S E Smith, Z Jiang, K Melnick, X Yuan, P W Kantoff, B Montgomery, S P Balk and M-E Taplin Prostate Cancer Prostatic Dis 2014 17: 325-331; advance online publication, August 5, 2014; 10.1038/pcan.2014.28 Abstract | Full Text Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy S B Stewart, J C Cheville, T J Sebo, I Frank, S A Boorjian, R H Thompson, M T Gettman, M K Tollefson, E C Umbriet, S P Psutka, E J Bergstralh, L Rangel and R J Karnes Prostate Cancer Prostatic Dis 2014 17: 332-337; advance online publication, August 26, 2014; 10.1038/pcan.2014.30 Abstract | Full Text Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study A K Morgans, K-H Fan, T Koyama, P C Albertsen, M Goodman, A S Hamilton, R M Hoffman, J L Stanford, A M Stroup and D F Penson Prostate Cancer Prostatic Dis 2014 17: 338-342; advance online publication, August 19, 2014; 10.1038/pcan.2014.31 Abstract | Full Text Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer M Valerio, P D Stricker, H U Ahmed, L Dickinson, L Ponsky, R Shnier, C Allen and M Emberton Prostate Cancer Prostatic Dis 2014 17: 343-347; advance online publication, September 2, 2014; 10.1038/pcan.2014.33 Abstract | Full Text Who dies from prostate cancer? A Patrikidou, Y Loriot, J-C Eymard, L Albiges, C Massard, E Ileana, M Di Palma, B Escudier and K Fizazi Prostate Cancer Prostatic Dis 2014 17: 348-352; advance online publication, October 14, 2014; 10.1038/pcan.2014.35 Abstract | Full Text Association of variants in genes related to the immune response and obesity with BPH in CLUE II D S Lopez, S B Peskoe, K K Tsilidis, J Hoffman-Bolton, K J Helzlsouer, W B Isaacs, M W Smith and E A Platz Prostate Cancer Prostatic Dis 2014 17: 353-358; advance online publication, September 16, 2014; 10.1038/pcan.2014.36 Abstract | Full Text A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer T B Dorff, S Groshen, D D Tsao-Wei, S Xiong, M E Gross, N Vogelzang, D I Quinn and J K Pinski Prostate Cancer Prostatic Dis 2014 17: 359-365; advance online publication, September 23, 2014; 10.1038/pcan.2014.37 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.